Chairman and CEO of the company Parker Petit said the company has been successful in reducing its adjusted EBITDA loss in the third quarter by almost $500,000 as compared to the second quarter of 2011 as well as improved sales in the wound care and spine markets. During this quarter, the company initiated its AmnioFix and EpiFix allografts.
Related Articles on Orthopedic Device Companies:
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer
More Insurance Companies Now Reimburse for TranS1’s AxiaLIF
MiMedx Reports $2.1M 3Q Revenue, 20-Fold Increase
Kennesaw, Ga.-based medical device company MiMedx Group recently reported third quarter revenue of $2.1 million, a 20-fold increase over the third quarter of 2010, according to a MiMedx news release.
How Health Systems Are Shaping Executive Leadership Teams to Drive Future Success
Recommended Live Webinar on Jul 30, 2025 11:00 AM - 12:00 PM CDT